Cardinal Health distributes pharmaceuticals and medical products to hospitals, pharmacies, and other healthcare providers. Its Pharmaceutical and Specialty Solutions business manages drug distribution and specialty-care services, while its medical activities provide procedure supplies, laboratory products, and logistics. The company also supports inventory management, patient access, and other services across the healthcare supply chain.
Cardinal Health Inc. (CAH) has a MarketKingdoms composite score of 71.3 (B+), an B-range rating. It ranks 216th of 1,866 covered companies, 7th of 78 in Healthcare (sector average 64.5) and 1st of 4 in Medical Distribution. Scores as of 2026-10-25.
Its strongest lenses are Industry opportunity at 91 (Healthcare average 81) and KPI momentum at 84 (Healthcare average 78). Its weakest lenses are Quality (profitability) at 38 (sector average 50) and Expansion (growth) at 60 (sector average 50).
| Lens | Type | CAH | Healthcare average | Medical Distribution average | Percentile in sector |
|---|---|---|---|---|---|
| Industry opportunity | Research signal | 91 | 81 | 91 | 100th |
| Stock selection | Research signal | 81 | 79 | 82 | 59th |
| KPI momentum | Research signal | 84 | 78 | 92 | 68th |
| Catalyst watch | Research signal | 77 | 74 | 76 | 72nd |
| Price (valuation) | Fundamental lens | 67 | 50 | 68 | 76th |
| Expansion (growth) | Fundamental lens | 60 | 50 | 54 | 72nd |
| Quality (profitability) | Fundamental lens | 38 | 50 | 36 | 33rd |
| Trend (momentum) | Fundamental lens | 67 | 50 | 51 | 69th |
The most recent call analysed was held on 2026-08-11 (fiscal 2026 Q4). MarketKingdoms checks what management promised on each call against what it later delivered.
The stock's valuation gap is -4.6%: its price is in line with the path its market, sector and industry moves explain. Factor sensitivity: market beta 0.90, sector beta 0.11, industry beta 0.87; the factor model explains 54% of its moves (R²).
| Company | Composite | Grade | Valuation gap |
|---|---|---|---|
| McKesson Corporation (MCK) | 70.0 | B+ | +12.2% |
| Henry Schein Inc. (HSIC) | 67.6 | B | -16.7% |
| Cencora Inc. (COR) | 64.3 | B | -7.0% |
Cardinal Health Inc. financial statements · Healthcare sector ranking · Medical Distribution industry ranking · All covered companies
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.